Case 05 — Davi Skin (DAVN, fka MW Medical)

CIK: 1059577 Ticker (OTC): DAVN Lineage: MW Medical, Inc. → Davi Skin, Inc. SIC (current): 2844 — Perfumes, Cosmetics & Toilet Preparations SIC (origin): medical devices / health services

Summary

CIK 1059577 is the seed lineage for Cane catalog heuristic #3 (reverse_merger_chain). MW Medical, Inc. — a medical-device-era shell registered in 1998 — emerges through the textbook 8-K Item 5.06 → 2.01 → 5.03 sequence as Davi Skin, Inc., a cosmetics issuer (SIC 2844), with the name change effective 2004-06-24 (EDGAR formerNames). The industry pivot from medical devices to perfumes/cosmetics is a clean sic_code_drift, and the post-merger float is exactly where the market-data confirmation page finds volume dislocations.

Dates/accessions below are EDGAR-confirmed; see _edgar-facts-davi-lati.md for the source filings.

EDGAR filing chronology (structural fingerprints)

Date	Form	Significance
1998	(registration)	MW Medical, Inc. — original EDGAR identity on CIK 1059577 (medical-device origin)
2001-04 / 2002-05	10-KSB	Regulation D private placements in the MW Medical era — the early offering precedent (acc 0001075793-01-500008, -02-000209)
2004-06-10	(corp action)	500-for-1 reverse stock split (approved at 2004-05-10 annual meeting)
2004-06-24	EX-2.1 8-K	Agreement & Plan of Merger; MW Medical → Davi Skin (name change effective; 8-K 5.06 → 2.01 → 5.03 legs surround) (acc 0001255294-04-000201)
2004-07-20	SC 14F1	Change-of-control information statement; Wallace convertible promissory note $570,775.30, convertible @ $0.20/sh (acc 0001255294-04-000214)
2004-09-15	S-8 + EX-5.1	Opinion of counsel (McDonald·Carano·Wilson LLP), registering 340,000 shares (acc 0001255294-04-000267)
2005-05-23	10-QSB	Regulation S offering — units (2 shares + 1 warrant) to four foreign investors (acc 0001255294-05-000310)
2005-08 → 2006-01	UPLOAD / CORRESP	SEC staff comment letters challenging the Reg S issuances (acc 0000000000-05-042920, -05-048374, -06-001113; 0001255294-06-000024)
2006-05-12	SB-2	Resale registration of the placement/convertible shares (acc 0001255294-06-000321)
2006–2012	10-KSB / 10-QSB / NT	Periodic + chronic late filings (NT 10-Q ×23) under the Davi Skin identity, cosmetics SIC 2844
2008	—	DAVN trades OTC on the post-merger float (see price/volume confirmation)
2012-08-27	(last filing)	Final EDGAR filing; REVOKED registration status on record

Per-heuristic scoring

#	Heuristic	Trip?	Earliest trip	Weight	Score
1	`name_recycling`	YES — formerName MW Medical → Davi Skin on one CIK	2004-06-24	3	3
2	`shell_reactivation`	PARTIAL — dormant medical-device shell reactivated via merger	2004	3	2
3	`reverse_merger_chain`	YES — 8-K 5.06 → 2.01 → 5.03 + EX-2.1 merger agreement	2004-06-24	3	3
4	`penny_stock_s1_s8`	YES — S-8 (340k sh, 2004-09-15) + SB-2 resale (2006-05-12)	2004-09-15	2	2
5	`late_filer_cluster`	YES — NT 10-Q ×23, NT 10-K ×10 across the Davi period	2005+	2	2
6	`going_dark_blackout`	PARTIAL — filings run to 2012-08-27, then REVOKED	2012	2	1
7	`filer_agent_overlap`	YES — filer agent `0001255294` also files LATI + Cane 13Ds	2004	3	3
8	`form_d_only_issuer`	NO — issuer files periodics	—	3	0
9	`reg_s_issuance`	YES — Reg S units to 4 foreign investors (10-QSB 2005-05-23)	2005-05-23	2	2
10	`reg_a_offering`	NO	—	2	0
11	`sic_code_drift`	YES — medical devices → cosmetics (SIC 2844), major-group shift	2004-06-24	2	2
12	`promissory_note_clauses`	YES — Wallace convertible note $570,775.30 @ $0.20 (SC 14F1)	2004-07-20	2	2
13	`opinion_letter_presence`	YES — EX-5.1 opinion, McDonald·Carano·Wilson (2004-09-15)	2004-09-15	3	3
14	`form_144_outlier`	UNKNOWN	—	2	0
15	`sec_staff_action`	YES — Reg S comment letters (2005–06) + REVOKED status	2005-08	3	3
16	`self_filer_for_material_capital`	NO	—	2	0

Headline structural score: 28 / 38 (EDGAR full-text-confirmed pass; accessions in _edgar-facts-davi-lati.md). Distinct firing heuristics (n_sig): 12 → clears the n_sig ≥ 2 gate. Tier: score 28 ≥ 10 → Tier 1 (daily review).

Precrime lead time

Earliest trip date: 2004-06-24 — the EX-2.1 merger agreement / name change trips reverse_merger_chain, name_recycling, and sic_code_drift simultaneously; the convertible-note control change (SC 14F1) and Ex-5 opinion follow within 90 days.
Confirmation window: the 2008 OTC float (DAVN) is where market data confirms the structural signal — volume dislocations cluster in the post-merger float (see stock-davi.md).
Lead time: flagged at the moment of emergence (2004), ~4 years before the 2008 float that the confirmation dimension scores, and 8 years before the 2012 REVOKED status.

Cane-scheme pattern match

Davi Skin is the origin exemplar of heuristic #3:

README.md names "MW Medical / Davi Skin shell-traffic" as the seed for reverse_merger_chain and cites the exact "8-K Items 5.06 → 2.01 → 5.03 sequence."
The medical-devices → cosmetics drift mirrors the RTSL chairs → film → pharma drift and the GP Solutions agriculture → cannabis drift — the same sic_code_drift fingerprint across unrelated industries.
Read alongside case-04-lati.md — the Tele-Lawyer → Dynamic Associates → Legal Access Technologies lineage on CIK 878146 — the two lineages show the catalog's two highest-weight heuristics (name_recycling, reverse_merger_chain) each anchored to a real 2001–2010 registrant, then generalizing forward to the modern cases.
The two are not merely adjacent: they share common control (Kyleen / Michael Cane, who file SC 13D on Legal Access Technologies via CIK 1144030) and the same EDGAR filing agent 0001255294 — a filer_agent_overlap thread that binds the LATI and Davi Skin shells. Both also raise capital the same way: convertible promissory notes plus exemption offerings (Reg D in the MW era, Reg S in the Davi era), each registration carrying an Ex-5 opinion of counsel.

See genealogy-davi.md for the combined lineage diagram and stock-davi.md for the DAVN/LGAL market-data confirmation.